Frontiers in Pharmacology | Translational Pharmacology

Case Report

Published on 11 Feb 2026

Platelet-rich plasma for the treatment of postoperative anastomotic fistula of the gastrointestinal tract: a case report

in Translational Pharmacology

Sihui Jia
Yawen Guo
Changkai Zhang
Xiaoyuan Sun
Licun Wang
Haiyan Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2026.1727021

247 views

Editorial

Published on 11 Feb 2026

Editorial: Targeting adipose tissue for the treatment of metabolic alterations

in Translational Pharmacology

Lorenzo Flori
Bruno Ramos-Molina
Vincenzo Calderone
Alma Martelli

Frontiers in Pharmacology

doi 10.3389/fphar.2026.1797423

297 views

Original Research

Accepted on 10 Feb 2026

Efficacy and safety of camrelizumab-based regimens in advanced squamous cell carcinoma patients: a prospective multicenter study

in Translational Pharmacology

Weijia Jiang
Wanren Peng
Dong Qian
Genhe Wang
Hong Qian
Wenxia Deng
Zishu Wang
Zhiyong Wei
Tai Ma
Dong Zhao

Frontiers in Pharmacology

104 views

Review

Accepted on 10 Feb 2026

Systems-Level Actions of Luteolin in Female Reproductive Disorders: From Molecular Mechanisms to Clinical Translation

in Translational Pharmacology

Lenah Saeed Binmahfouz

Frontiers in Pharmacology

Review

Accepted on 09 Feb 2026

Advances in Managing Knee Osteoarthritis: Exploring Ultrasound-Guided Radiofrequency Thermocoagulation and its Molecular Impact

in Translational Pharmacology

Xuetian Zhou
Chao Quan
Xiuling Luo

Frontiers in Pharmacology

Original Research

Published on 09 Feb 2026

Unraveling the role of 3-mercaptopyruvate sulfurtransferase-derived hydrogen sulfide in triple-negative breast cancer chemoresistance

in Translational Pharmacology

Sousanna Hakim
Danira A. Habashy
Kelly Ascenção
Rana A. Youness
Carole Bourquin
Csaba Szabo
Mohamed Z. Gad
Reham M. Abdelkader

Frontiers in Pharmacology

doi 10.3389/fphar.2026.1748950

397 views

Mini Review

Accepted on 05 Feb 2026

Recent Developments in Quercetin Nanomedicine and Application in Osteoarthritis and Rheumatoid Arthritis Rherapy

in Translational Pharmacology

Yuan Zhu
Hongxuan Chen
Yuanling Yi
Fuhui Zhou
Wenzhi Zhou
Shenghui Zhong

Frontiers in Pharmacology

116 views

Editorial

Accepted on 04 Feb 2026

Editorial: Advancing Antibiotic Candidates for Eradication of Persistent Bacterial Infections

in Translational Pharmacology

Laurent Bekale
Jessica Amber Jennings
Xilin Zhao

Frontiers in Pharmacology

209 views

Original Research

Accepted on 28 Jan 2026

Real-world clinical experience with upadacitinib in a cohort of Italian patients with axial spondyloarthritis

in Translational Pharmacology

Roberta Ramonda
Mariagrazia Lorenzin
Antonio Carletto
Maria Sole Chimenti
Maria Manara
Giacomo Cozzi
Alen Zabotti
Roberta Foti
Antonio Carriero
Ariela Hoxha

Frontiers in Pharmacology

181 views

Review

Published on 28 Jan 2026

Recent advances in mitochondria-targeted porphyrin-based metal-organic frameworks for enhanced cancer therapy

in Translational Pharmacology

Jiawen Tao
Zhifei Yuan
Mengjiao Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2026.1764901

575 views

Original Research

Published on 21 Jan 2026

A risk prediction model for medication safety: assessing cardiopulmonary adverse outcomes in 11,252 patients treated with ulinastatin

in Translational Pharmacology

Rutong Hua
Ying Zhang
Jianxiong Deng
Qiqi Wen
Guozheng Li
Rende Fang
Zhuoyu Chen
Yuxuan Cao
Xi-Yong Yu
Jin Li

Frontiers in Pharmacology

doi 10.3389/fphar.2026.1746148

506 views

Original Research

Accepted on 19 Jan 2026

Peptide-based antimicrobial effect against carbapenem-resistant Acinetobacter baumannii: preclinical drug assessment and translational potential

in Translational Pharmacology

Hak Jun Lee
Seung Jun Lee
Yoon Hyun Sung
Seung Min Park
Seung Pyo Choi
Yang Mee Kim
Young Kyung Yoon

Frontiers in Pharmacology

247 views

Correction

Published on 19 Jan 2026

Correction: Punicalin attenuates breast cancer-associated osteolysis by inhibiting the NF-κB signaling pathway of osteoclasts

in Translational Pharmacology

Tao Li
Guangyao Jiang
Xuantao Hu
Daishui Yang
Tingting Tan
Zhi Gao
Zhuoyuan Chen
Cheng Xiang
Shizhen Li
Zhengxiao Ouyang

Frontiers in Pharmacology

doi 10.3389/fphar.2026.1678237

359 views
1 citation

Review

Published on 13 Jan 2026

HtrA2/Omi: potential therapeutic targets for neurodegenerative diseases

in Translational Pharmacology

Liting Xu
Min Zeng

Frontiers in Pharmacology

doi 10.3389/fphar.2026.1705666

619 views

Original Research

Published on 13 Jan 2026

PTX-loaded, polysorbate 80-functionalized brain-targeting pullulan nanoparticles for drug delivery

in Translational Pharmacology

Huabing Yuan
Lu Han
Hao Deng
Yue Tan
Yi Yang
Yi Liu
Jiaxin Ying
Mengqi Fang
Hui Wei
Zhihe Tao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1666997

711 views

Editorial

Published on 13 Jan 2026

Editorial: Nutrition as a pharmacological approach to metabolic disorders and ageing

in Translational Pharmacology

Chiara Ruocco
Amit Kumar Singh
Enzo Nisoli
Maurizio Ragni

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1770988

779 views

Original Research

Published on 08 Jan 2026

Donor lymphocyte infusion combined with azacitidine after allogeneic HSCT in pediatric AML: a single-center retrospective analysis

in Translational Pharmacology

Ana Maria Bica
Andra Daniela Marcu
Cristina Georgiana Jercan
Iuliana Iordan
Andreea Nicoleta Serbanica
Irina Avramescu
Matei Colita
Delia Codruta Popa
Ileana Constantinescu
Alexandra Mihaela Ichim

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1727492

910 views

Correction

Published on 08 Jan 2026

Correction: Rubidium chloride targets Jnk/p38-mediated NF-κB activation to attenuate osteoclastogenesis and facilitate osteoblastogenesis

in Translational Pharmacology

Zhengxiao Ouyang
Qianli Huang
Bin Liu
Hong Wu
Tang Liu
Yong Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1678247

525 views

Original Research

Published on 07 Jan 2026

Refined target-mediated drug disposition modeling of the anti-tissue factor pathway inhibitor antibody MG1113 in cynomolgus monkeys and rabbits

in Translational Pharmacology

Heechun Kwak
Yoo-Seong Jeong
Jiyoung Kim
Minsoo Lee
Seonyoung Byoun
Yasunori Aoki
Suk-Jae Chung
Wooin Lee

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1745702

977 views

Correction

Published on 07 Jan 2026

Correction: Hesperetin prevents bone resorption by inhibiting RANKL-induced osteoclastogenesis and Jnk mediated Irf-3/c-Jun activation

in Translational Pharmacology

Qiang Zhang
Xinqiao Tang
Zhong Liu
Xiaoxia Song
Dan Peng
Wei Zhu
Zhengxiao Ouyang
Wanchun Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1678215

427 views

Original Research

Published on 06 Jan 2026

Synergistic therapy for diabetic retinopathy via dual blockade of VEGF-A and TNF-α with a bispecific nanobody

in Translational Pharmacology

Chenlu Wu
Yue Shen
Chengnan Xu
Chong Bi
Chenyue Yan
Jinping Niu
Wenyun Zheng
Xingyuan Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1729606

992 views

Opinion

Published on 05 Jan 2026

What role will physiological resilience play in brown-white fat dynamic in obesity management?

in Translational Pharmacology

Oksana Zayachkivska
Iryna Kovalchuk
Iryna Muzyka
Maryana Savytska

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1691149

848 views

Review

Published on 19 Dec 2025

Engineering immunity with CAR-NK cells: advancing the frontiers of cancer immunotherapy

in Translational Pharmacology

Vlad Andrei Cianga
Ion Antohe
Cosmin Minciună
Angela Dăscălescu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1738558

1,966 views

Review

Published on 12 Dec 2025

Relevant pharmacokinetics, bioavailability, and bioequivalence studies on Chlorpheniramine maleate (various species): a review

in Translational Pharmacology

César Alas-Pineda
Dennis J. Pavón-Varela
Kristhel Gaitán-Zambrano
Gustavo Ferrer

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1737690

2,229 views